287 related articles for article (PubMed ID: 22153756)
1. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
Berry DL; Halpenny B; Hong F; Wolpin S; Lober WB; Russell KJ; Ellis WJ; Govindarajulu U; Bosco J; Davison BJ; Bennett G; Terris MK; Barsevick A; Lin DW; Yang CC; Swanson G
Urol Oncol; 2013 Oct; 31(7):1012-21. PubMed ID: 22153756
[TBL] [Abstract][Full Text] [Related]
2. When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer.
Underhill ML; Hong F; Berry DL
Health Qual Life Outcomes; 2014 Oct; 12():159. PubMed ID: 25344101
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.
Berry DL; Halpenny B; Wolpin S; Davison BJ; Ellis WJ; Lober WB; McReynolds J; Wulff J
J Med Internet Res; 2010 Dec; 12(4):e67. PubMed ID: 21169159
[TBL] [Abstract][Full Text] [Related]
4. Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
Berry DL; Hong F; Blonquist TM; Halpenny B; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M; Somayaji P
J Urol; 2018 Jan; 199(1):89-97. PubMed ID: 28754540
[TBL] [Abstract][Full Text] [Related]
5. Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.
Shirk JD; Crespi CM; Saucedo JD; Lambrechts S; Dahan E; Kaplan R; Saigal C
Patient; 2017 Dec; 10(6):785-798. PubMed ID: 28623628
[TBL] [Abstract][Full Text] [Related]
6. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
Bosco JL; Halpenny B; Berry DL
Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
[TBL] [Abstract][Full Text] [Related]
7. Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial.
Kaplan AL; Crespi CM; Saucedo JD; Connor SE; Litwin MS; Saigal CS
Cancer; 2014 Sep; 120(17):2721-7. PubMed ID: 24816472
[TBL] [Abstract][Full Text] [Related]
8. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
[TBL] [Abstract][Full Text] [Related]
9. Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW; Jones RA; Krupski TL; Berry DL
BMC Med Inform Decis Mak; 2019 Jan; 19(1):6. PubMed ID: 30626400
[TBL] [Abstract][Full Text] [Related]
10. Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.
Diefenbach MA; Benedict C; Miller SM; Stanton AL; Ropka ME; Wen KY; Fleisher LG; Mohamed NE; Hall SJ
Transl Behav Med; 2018 Nov; 8(6):876-886. PubMed ID: 29982747
[TBL] [Abstract][Full Text] [Related]
11. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.
Berry DL; Wang Q; Halpenny B; Hong F
Patient Educ Couns; 2012 Aug; 88(2):262-7. PubMed ID: 22608696
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a decision support intervention for reducing decisional conflict in patients with elevated serum prostate-specific antigen: A randomized controlled trial.
Wang TJ; Chiu PP; Chen KK; Hung LP
Eur J Oncol Nurs; 2021 Feb; 50():101865. PubMed ID: 33212360
[TBL] [Abstract][Full Text] [Related]
13. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
[TBL] [Abstract][Full Text] [Related]
14. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
[TBL] [Abstract][Full Text] [Related]
15. Educating African American men about the prostate cancer screening dilemma: a randomized intervention.
Taylor KL; Davis JL; Turner RO; Johnson L; Schwartz MD; Kerner JF; Leak C
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2179-88. PubMed ID: 17119044
[TBL] [Abstract][Full Text] [Related]
16. Informing men about prostate cancer screening: a randomized controlled trial of patient education materials.
Ilic D; Egberts K; McKenzie JE; Risbridger G; Green S
J Gen Intern Med; 2008 Apr; 23(4):466-71. PubMed ID: 18373146
[TBL] [Abstract][Full Text] [Related]
17. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.
Cuypers M; Lamers RE; Kil PJ; van de Poll-Franse LV; de Vries M
Trials; 2015 May; 16():231. PubMed ID: 26012700
[TBL] [Abstract][Full Text] [Related]
18. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
[TBL] [Abstract][Full Text] [Related]
19. Decision aids for people facing health treatment or screening decisions.
Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
[TBL] [Abstract][Full Text] [Related]
20. Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
Thurtle D; Jenkins V; Freeman A; Pearson M; Recchia G; Tamer P; Leonard K; Pharoah P; Aning J; Madaan S; Goh C; Hilman S; McCracken S; Ilie PC; Lazarowicz H; Gnanapragasam V
Eur Urol; 2021 Nov; 80(5):661-669. PubMed ID: 34493413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
